chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient experienced pain and swelling of injection site immediately following vaccination. The redness continued and made a big welp extending down the arm
The patient's mother identified her child was twelve years of age and did complete that he was age 12 on the front page of the Prevaccination  Checklist form. The nurse administered the Pfizer vaccine in a Public Health setting, as requested by the patient's mother. Upon return back to the facility to begin documentation on the patient receiving the vaccine, the nurse identified the patient is eleven years of age.
No adverse event; administered of improperly stored MMR II; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On 28-JUL-2022, the patient was vaccinated with improperly stored with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human albumin (rHA) (M-M-R II) 1 dose, lot #U023829, expiration date: 30-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided). The temperature excursion was 10.1 Celsius (C) for 15 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported (no adverse event).  This is one of four reports received from the same reporter.; Sender's Comments:  US-009507513-2208USA003406: US-009507513-2208USA003578: US-009507513-2208USA003290:
Extreme pain in back and stomach after second dose; Extreme pain in back and stomach after second dose; couldn't barely walk day after; eased off pain still there; This is a spontaneous report from a contactable consumer (patient) or other non hcp.   A 37-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 28Jun2021 16:45 (at the age of 37-years-old) as dose 2, single for COVID-19 immunization. Medical history included contraception from an unknown date and unknown if ongoing. Concomitant medication included butalbital, caffeine, paracetamol (FIORICET) taken for contraception, start and stop date were not reported. The patient previously took macrobid [clarithromycin] and experienced drug hypersensitivity. Previously patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 07Jun2021 05:45 (at the age of 37-years-old) as dose 1, single for COVID-19 immunization. No COVID prior to the vaccination. COVID not tested post vaccination. On 29Jun2021 07:00, the patient experienced extreme pain in back and stomach after second dose, couldn't barely walk day after, eased off pain still there. The outcome of the event eased off pain still there was recovering. The outcome of the events extreme pain in back and stomach after second dose, couldn't barely walk day after was unknown.  No Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Per mother, child had symptoms the next day after immunizations.  On 1-25-08 child came to clinic with symptoms of swollen left deltoid muscle, approximately 2"; skin was red and hot to touch.  Advised cool compress, Tylenol and Benadryl to help symptoms.
fever; swelling at the injection site; tired; light continued pain in left leg between knee cap, described as ache; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B28) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache). At the time of the report, PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use included unspecified eye drops. The patient was treated with Tylenol (paracetamol) and vitamin d 50,000. The reporter did not provide an assessment for the event (s), PYREXIA (fever), INJECTION SITE SWELLING (swelling at the injection site), FATIGUE (tired) and ARTHRALGIA (light continued pain in left leg between knee cap, described as ache).
Diagnosed with COVID-19 positive after receiving the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Diagnosed with COVID-19 positive after receiving the vaccine) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Diagnosed with COVID-19 positive after receiving the vaccine). At the time of the report, COVID-19 (Diagnosed with COVID-19 positive after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Non-significant follow-up appended: no new info, added hx; Sender's Comments: Based on mechanism of action of mRNA -1273 vaccine, the event COVID-19 positive is assessed as unlikely related to mRNA-1273.
Shortly after second dose, Patient noticed spells of dizziness and pre-syncope as well as syncope episodes. Patient generally felt weak and as time passed more symptoms appeared (vertigo, anxiety, rashes, joint pain, migraines, heavy periods, etc) sending patient to multiple visits with various specialists. In 2018 patient was finally diagnosed with SLE/Lupus.
Information was received 11-JUL-2017 via a phone call from a medical assistant who reported that on 02-MAY-2017, a male patient of unspecified age, was inadvertently administered an expired dose of MMR II (Lot # L007577, expiration date 05-MAR-2017). Concomitant product included MERCK (Lot# not provided). No adverse effect was reported. No additional information was provided. Additional information was requested.
This spontaneous report as received from a physician via a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 26-SEP-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB "10Pk 10mcg/1mL SD LLok Cap AD", lot # L001441 with expiration date 17-AUG-2017 (route of administration and anatomical location were not reported). There were no concomitant therapies and adverse effects reported. No product quality complain was involved. On an unspecified date, the RECOMBIVAX HB had a temperature excursion of 34 F (1.11 Celsius Degrees) for 56 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and type of excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
Person complained of light headiness, dizziness and blurred vision after receiving the first dose of the Pfizer vaccine. EMS was called and treated the individual on scene and was released on their own.
The left side of my face and tongue got numb / tingly. It began to lessen after about an hour and continues to lessen as the day goes on. It is believed that my body may have just responded quickly. I was monitored for a few extra minutes, and then released.
Fever day 1 101.5; Fever  day 2 99.5; chills, weakness, fatigue
Information has been received from a consumer concerning her 3 year old daughter who was vaccinated with a dose of MMR. There was no concomitant medication. Subsequently, the patient developed autism. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Upon internal review, autism was determined to be an other important medical event (OMIC). No further information is available.
pt recv vax & exp chills, fever, sweats, arm swelling returned to clinic, ice packs, medrol dose pack given;
Shots given in RT deltoid muscle; Self care after immunizations. Patient verbalized understanding. Patient fainted, someone assisted me  with the patient. He was strong, slipped out of our arms. Head hit the floor. Deep gash over right eye. Pressure applied. Dr. assisted in checking the patient. Someone also assisted in care of patient B/P vital signs and stabilizing patient, 911 was called and responded.
Received Pfizer vaccines on  4/16, 5/7, 11/9/21 COVID-19 positive by PCR on  1/31/22 admitted to hospital on 1/31/22 w/ GI bleed, anemia, SOB underlying COPD, obesity, CHF, DM2, CAD, CML
Onset symptoms: Left arm tingling after injection and shortness of breath upon vaccine administration. Treatment: no medical treatment was given. rest resolved the symptoms.  Outcome: rest and BP check  resolved the symptoms. patient was  discharged to POV/Home.
Left arm swollen and red 48 hrs after vaccination. Rx with Benadryl-recovered ~ 48 hrs.
A report was received from a healthcare professional on 10/20/2003 concerning a 46 year old female vaccinee who experienced an injection site reaction with swelling, redness and pain 1 day after receiving Fluvirin on 10/10/2003. On 10/11/2003 the vaccinee experienced an injection site reaction with swelling, redness and pain.  The affected area was 5cm by 5cm.  The vaccinee recovered 1 week after onset. There was insufficient information to determine the reporter's causality assessment.   Follow up pending. Update 1, 02 December 2003: Follow up information received from a healthcare professional indicated that the vaccinee who experienced severe swelling, redness and pain at the injection site, recovered after 1 week.
lupus; daughter is sick; daughter's "life is flipped upside down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 16-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) at the age of 15 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Caller's daughter received the first and second dose of the Pfizer COVID-19 vaccine. Caller's daughter received the vaccine "when she was 15" years old), when the patient was 15 years old, for COVID-19 immunisation, reaction(s): "Lupus". The following information was reported: SYSTEMIC LUPUS ERYTHEMATOSUS (medically significant), outcome "unknown", described as "lupus"; ILLNESS (non-serious), outcome "unknown", described as "daughter is sick".   Clinical course: Caller's daughter received the first and second dose of the Pfizer COVID-19 vaccine. Caller's daughter received the vaccine "when she was 15" years old. Caller mentioned that her daughter "now has lupus" and the vaccine "gave her Lupus".  Caller also added that "no one in her side or her husband's side of the family has that type of auto-immune disease". Caller also mentioned that she read from the website that the "Pfizer vaccine causes this type of auto-immune dis-ease". Caller was frustrated that her "daughter was sick" and that her daughter's "life is flipped up-side down". Caller added that her daughter's "dreams of her future, of what she wanted to do was totally gone because now she won't be medically fit for it". Caller was also concerned with the medical bills and her daughter's "life long treatment". Caller asked if it was possible to be given the first and second dose of the Pfizer COVID-19 vaccine with the same lot numbers.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
chills; headache; fatigue; This is a spontaneous report from a contactable consumer (patient) via Pfizer sales representative. A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date not reported) as unknown, single for COVID-19 immunization. Medical history was not reported. Concomitant medications were none. On an unspecified date, the patient experienced chills, headache and fatigue. Clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2011, the patient was inoculated with ZOSTAVAX at a medical office as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. In 2015, the patient was treated at the same medical office for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
J96.00 ACUTE RESPIRATORY FAILURE 12/14/2022 COVID-19 DISEASE
abdominal pain, cramping, nausea, vomiting, diarrhea. Treated with prochlorperazine
9/9/21 pos for covid 9/15/21: admitted to hospital and put on steroids and had 1 dose of tocilizumab pt intubated and put on ventilator pt expired on 9/20/21 of COVID
I don't want to make a big deal about this BUT - I am 60, a heavy smoker, In very good health for my age. I have developed a Tic - a very small area - almost right betwwen my  eyes , above the bridge of my nose , closer to wear my right eyebrow starts by my nore , has a thobbing sensation - like a "Tic". It vibrates off and on for lack of a better description. I can see it when it occurs - like the nerves are twitchinng just under the skin. I have zero history of "Tics" or any involuntary Muscle or Nerve Movements. I do not suffer from anxiety or any other disorder that I have ever been aware of. I have some COPD (100yr smoker) and the "tic" is prevalent immediatley after I cough - which is smoething I do a lot. It lasts only a few seconds then goes away. I can Palpate the area during the "tic" and feel the movement under the skin - it feels like a really fast pulse sort of.  I have not notified any medical personnel and do not feel that it is a serious matter  - just kind of uncomfortable. There is no pain or discomfort associated with it - It just feels funny to me. I rarely go to the Doctor , I am as normal as it gets and tough as a nail. I just felt like I should say something - this started a few days after my 2nd shot - I have never experianced anything like this before in my life. I am Pre Hypertensive 135/88-90 , slightly overweight and a heavy smoker and Moderate drinker. I have felt the "Tic" approx 7 times in the time it took me to type this up. Thank You.
I took the vaccine at about 12 noon on 8/16/2021 and about 3:00 p.m. I felt a burning sensation at the very top of my head, it lasted about 5 sections then stopped, it happened again about 15 minutes later and at least three times that day. It also felt like my blood pressure was up, I checked it and it was high the first time and took it again and it was normal. The second day it happened again but not with the same burning sensation, on the second day but it just didn't feel right,  I took 500 milligrams of tylenol which made me feel a little better but that evening my head felt very hot, not like fever, I placed an ice pack on my head which helped it feel better. My ears felt hot and I generally didn't feel good. The third day I continued to feel sensations in the top of my head for a second and then it was on the side of my head for a second or two. Today is day four and I am now recording every event and realized that unusual sensation in my head is occurring more than I realized, lasting  for only a second but travels from my head to my nose area. It is very concerning to think that my brain may be affected by this vaccine. I generally feel better but the unusual sensations continue. I called my doctor on day three and they said they had  not head of this reaction, the doctor said she could check my scalp but I told her nurse it is on the inside of my head/scalp, it is not external.
Information has been received from a 68 year old consumer reporting on herself with sulfa allergy and no pertinent medical history who on 08-AUG-2010, was vaccinated with a dose of ZOSTAVAX (Merck) 0.65 ml, subcutaneously (lot number not reported). Concomitant therapy included EXTRADOL. In October 2010, the consumer was diagnosed with shingles. The consumer sought unspecified medical attention. The consumer did not receive any treatment for the event and no laboratories were performed. At the time of the report the patient was recovered. Follow up information has been received from a registered nurse informing that she was unfamiliar with the patient and did not have any additional information on the adverse event. No further information is available.
Within 3 hours after injection. Extreme left arm pain 8/10. Could not move arm/lost range of motion for 48 hours. Could not sleep due to the pain.
12/2/2021 @ 16:25: Was informed that employee is in Hospital on a ventilator and is possibly brain dead.
Muscle aching (mild side effects); Tired (mild side effects); This case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain and tiredness. On an unknown date, the outcome of the muscle pain and tiredness were unknown.   It was unknown if the reporter considered the muscle pain and tiredness to be related to Shingrix.     Additional Information: GSK Receipt Date: 15-SEP-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient asked how long after the Shingrix vaccine would patient start to have mild side effects (muscle aching and tired). Additional supportive information: The follow-up would not possible, as no contact, details were available.
This spontaneous report as received from a nurse refers to a 9 month old patient. No concurrent conditions or medical history were provided. On 09-JUL-2014, the 9 month old patient was vaccinated with the first dose of PROQUAD (Merck) injection (dose, route of administration, indication, lot# and expiry date unspecified). No concomitant medications were reported. No adverse symptoms were reported. Additional information has been requested.
Headache that began shortly after vaccination and has continued into day four. Bruising at the site of injection. On the morning of day four, redness and itchiness appeared.
Case number PHEH2015US000738, is an initial spontaneous report received from a nurse on 05 Jan 2015 and combined follow up report received from the nurse on 19 Mar 2015. This report refers to a 11-year-old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number: M14068), intramuscularly on 05 Jan 2014, which had a temperature excursion of 1 degree Celsius for 20 hours. No adverse event was reported following this administration error. The patient was contacted, waited for 60 days and then the patient received a repeated dose of MENVEO on 11 Mar 2015 due to possible non-viability. The patient was doing fine. No adverse event was reported following this administration error. Combined follow up report received from the nurse on 19 Mar 2015: Report type changed from other to spontaneous, patient's demographics and new event inappropriate schedule of vaccine administered was added.
Burning in my left forearm 15 minutes after injection. The next day the burning spread through out my body. 3 days after the injection excessive sweating. The burning is muscular.
Patient received vaccines at 2:30pm 10-29-19. Approximately 8:00 am on 10-30-19 began to have abdominal pain. The pain worsened throughout the day and patient also developed fever and chills. Patient went to ED and was told by ED doctor the symptoms were most likely due to an adverse reaction to vaccines. Patient was not admitted and all symptoms are resolved at this time.
SLIGHT SWELLING-NOT MUCH, FLAT BUMPY RASH, RED SIZE OF GOLF BALL
Tightness to breath without any sign of cough; Pain; My skin was very hot but I did not run a fever; I became very nauseous; Chills; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on the left arm on 07Apr2021 at 12:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on the left arm on 17Mar2021 at 13:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 20:00, the patient was very nauseous and experienced chills one week after the shot. He also experienced pain, tightness to breath without any sign of cough and skin was very hot. His skin was very hot but he did not run a fever. The chills were awful and he never lost his taste or smell. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very nauseous, chills, pain, tightness to breath without any sign of cough and skin was very hot was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.